LENZ Therapeutics Market Cap

LENZ Therapeutics has a market cap or net worth of $405.22 million as of April 30, 2024. Its market cap has increased by 135.32% in one year.

Market Cap

405.22M

Enterprise Value

219.72M

1-Year Change

135.32%

Ranking

#3110

Market Cap Chart

Since the IPO on June 25, 2021, LENZ Therapeutics's market cap has decreased from $951.31M to $405.22M, a decrease of -57.40%. That is a compound annual growth rate of -25.88%.

Market Cap History

Date	Market Cap	% Change
Apr 30, 2024	132.00M	-3.86%
Apr 29, 2024	137.30M	4.97%
Apr 26, 2024	130.80M	1.79%
Apr 25, 2024	128.50M	-2.58%
Apr 24, 2024	131.90M	-0.38%
Apr 23, 2024	132.40M	0.15%
Apr 22, 2024	132.20M	-0.83%
Apr 19, 2024	133.30M	-8.38%
Apr 18, 2024	145.50M	-1.22%
Apr 17, 2024	147.30M	-11.10%
Apr 16, 2024	165.70M	-2.59%
Apr 15, 2024	170.10M	-6.59%
Apr 12, 2024	182.10M	0.72%
Apr 11, 2024	180.80M	3.31%
Apr 10, 2024	175.00M	2.58%
Apr 9, 2024	170.60M	0.41%
Apr 8, 2024	169.90M	0.47%
Apr 5, 2024	169.10M	-1.00%
Apr 4, 2024	170.80M	-3.23%
Apr 3, 2024	176.50M	0.97%
Apr 2, 2024	174.80M	-
Apr 1, 2024	174.80M	-5.92%
Mar 28, 2024	185.80M	2.43%
Mar 27, 2024	181.40M	30.22%
Mar 26, 2024	139.30M	2.58%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sonida Senior Living	422.01M
Larimar Therapeutics	420.76M
Nevro	420.76M
Entrada Therapeutics	420.35M
Travere Therapeutics	417.78M
Neurogene	415.09M
Tourmaline Bio	413.68M
Cibus	410.11M

Market Cap Rankings